* German ruling parties agree extra economic support measures
* Bayer jumps on future Roundup cancer claims deal
* Unilever slides on underwhelming sales growth target
* BOE pushes out negative interest rate timeline (Updates to close)
By Shreyashi Sanyal and Susan Mathew
Feb 4 (Reuters) - European shares extended their rally to a fourth straight day on Thursday, as investors hoped for a swifter global economic recovery, while Unilever's disappointing targets weighed on London's blue-chip index.
The STOXX 600 index .STOXX rose 0.6%, while London's FTSE 100 .FTSE ended flat, underperforming regional peers for a second straight day, as consumer giant Unilever ULVR.L slumped 6.2% after its sales growth target underwhelmed investors. .L
A slide in oil majors BP BP.L and Royal Dutch Shell RDSa.L also weighed, with Shell reporting its lowest annual profit in at least two decades. O/R .FTNMX8350 and the sterling GBP= rose as money markets pushed bets on negative UK interest rates out to February 2022 after Bank of England said Britain's banks would need at least six months to prepare for sub-zero rates. BoE look unlikely to cut rates anytime soon, with a six-month adjustment period meaning the UK economy will be well into its recovery by the time they are even considered," said Joshua Mahony, senior market analyst at IG.
Italian shares .FTMIB gained 1.7% to close at a one month high, extending a rally after former European Central Bank chief Mario Draghi accepted the task of forming a new government on Wednesday.
The prime minister designate will conclude his formal consultations with parties on Saturday, the parliament's press office said in a statement on Thursday. 5.3% jump in shares of Bayer BAYGn.DE lifted Germany's DAX .GDAXI to one-month highs after the life science company struck a $2 billion deal to resolve future legal claims that its widely used weedkiller Roundup causes cancer. Germany's ruling coalition parties on Wednesday agreed a batch of additional measures to support those hit hard financially by the COVID-19 pandemic. markets remained hopeful after Democrats pushed ahead on Wednesday with a manoeuvre to pass U.S. President Joe Biden's $1.9 trillion COVID-19 relief package without Republican support. other companies reporting earnings, Swiss drugmaker Roche ROG.S was the top boost on the STOXX 600 after it forecasted a rise in 2021 sales and profit thanks to surging demand for COVID-19 tests.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.